Pharmacogenomic and molecular docking studies on the cytotoxicity of the natural steroid WORTMANNIN (cas 19545-26-7) against multidrug-resistant tumor cells

Add time:08/27/2019    Source:sciencedirect.com

WORTMANNIN (cas 19545-26-7) is a cytotoxic compound derived from the endophytic fungi Fusarium oxysporum, Penicillium wortmannii and Penicillium funiculosum that occurs in many plants, including medicinal herbs. The rationale to develop novel anticancer drugs is the frequent development of tumor resistance to the existing antineoplasic agents. Therefore, it is mandatory to analyze resistance mechanisms of novel drug candidates such as wortmannin as well to bring effective drugs into the clinic that have the potential to bypass or overcome resistance to established drugs and to substantially increase life span of cancer patients. In the present project, we found that P-glycoprotein-overexpressing tumor cells displaying the classical multidrug resistance phenotype toward standard anticancer drugs were not cross-resistant to wortmannin. Furthermore, three point-mutated PIK3CA protein structures revealed similar binding energies to wortmannin than wild-type PIK3CA. This protein is the primary target of wortmannin and part of the PI3K/AKT/mTOR signaling pathway. PIK3CA mutations are known to be associated with worse response to therapy and shortened its activity toward wild-type and mutant PIK3CA with similar efficacy.

We also recommend Trading Suppliers and Manufacturers of WORTMANNIN (cas 19545-26-7). Pls Click Website Link as below: cas 19545-26-7 suppliers

Prev:Prevention of the WORTMANNIN (cas 19545-26-7)-induced inhibition of phosphoinositide 3-kinase by sulfhydryl reducing agents
Next:Effects of WORTMANNIN (cas 19545-26-7), sodium nitroprusside, insulin, genistein, and guanosine triphosphate on chemotaxis and cell growth of Entodinium caudatum, Epidinium caudatum, and mixed ruminal protozoa)